yt:channel:F9IOB2TExg3QIBupFtBDxg F9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2007-05-10T15:05:05+00:00 yt:video:inpY-dGKyuA inpY-dGKyuA UCF9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2026-07-15T11:51:38+00:00 2026-07-17T06:38:02+00:00 Basics of cancer prevention Check out Dr. Michael Cohen’s YouTube channel for more content, https://www.youtube.com/@theaccidentaldr yt:video:VqESPunAx0A VqESPunAx0A UCF9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2026-07-11T16:05:38+00:00 2026-07-17T12:02:47+00:00 Spike protein science and corruption The connection between mRNA COVID vaccines and cancer relapse and occurrence. By Prof Angus Dalgleish MD FRCP FRACP FRCPath FMedSci My name is Professor Angus Dalgleish. I am an oncologist and immunologist with decades of experience in cancer immunotherapy and HIV research, including early clinical use of cancer immunotherapy in the United Kingdom long before checkpoint inhibitors were approved. I am Professor Emeritus and Foundation Chair of Oncology at the University of London, and Principal of the Institute of Cancer Vaccines and Immunotherapy. Beginning in late 2021, I observed a series of unexpected cancer relapses and unusually aggressive disease presentations among patients whose conditions had remained stable for years. A consistent pattern quickly became apparent: these relapses followed repeated COVID booster administration. These were patients in long-term remission who suddenly relapsed after being advised to receive additional doses of the vaccine. Despite the seriousness of these observations, there was little willingness to openly investigate these potential safety signals. From my background in HIV research and immunology, including early work involving the CD4 receptor, I was particularly sensitive to signals involving T-cell function and immune dysregulation. This led me to become concerned that repeated boosting strategies might contribute to impaired immune surveillance in vulnerable individuals, a concern later supported by evidence of exhausted T-cell responses following repeated vaccination. Over time, however, it became increasingly clear that the pattern extended far beyond relapse in vulnerable cancer patients alone. I began observing something far more alarming: unusually aggressive cancers, advanced-stage disease in younger individuals, and clinical presentations that differed sharply from what we would normally expect in routine oncology practice. Something broader — and far more concerning — appeared to be emerging. In my own clinical practice, I observed a marked increase in unexpected cancers among boosted patients, including breast, prostate, pancreatic, lymphoma, gall bladder, glioma, and bladder cancers. Some of the most striking observations came from colorectal cancer surgeons, who described a shift from earlier-stage, more routinely detected disease toward patients presenting with metastatic stage IV cancers and unusual thrombotic features. Increasingly, these patterns extended beyond clinical settings and into personal lives. I watched close friends develop aggressive late-stage cancers and rapidly deteriorate following repeated booster administration. At that point, the issue no longer felt purely academic or theoretical. It became deeply personal. I became increasingly concerned by unresolved questions surrounding the biologic behavior of mRNA-based platforms. Emerging literature proposed several biologically plausible mechanisms linking these vaccines to cancer progression, including immune dysregulation, vascular injury, and effects involving oncogenic and tumor-suppressor pathways. The consistency of these clinical observations, combined with emerging mechanistic evidence, should have prompted far greater scientific scrutiny and open investigation than they received. Instead, many clinicians and researchers became increasingly hesitant to openly question or investigate these potential safety signals at all. As a UK citizen, I found it striking that several members of the Royal Family, who were vaccinated, publicly disclosed unexpected cancer diagnoses during the same period many clinicians were reporting unusually aggressive cancers more broadly. Given what we know already, I have no doubt in my mind that the mRNA vaccine likely played a significant role in the development of these unexpected cancers. I raise this not to imply certainty regarding any individual case, but to illustrate how difficult open scientific discussion surrounding these broader patterns has become, even when the observations are highly visible. Science does not advance through silence, suppression, or reputational protection. It advances through rigorous inquiry, transparent debate, independent replication, and the courage to follow evidence wherever it leads. I believe there is now an urgent need for independent investigation into the potential relationship between repeated mRNA vaccination, immune dysregulation, and aggressive cancer progression, particularly in vulnerable populations. If legitimate scientific concerns cannot be openly examined, public trust in medicine and public health institutions will continue to erode. Accountability and transparency are not threats to science. They are the foundation that makes science worthy of public trust. yt:video:U66ML0GxdsM U66ML0GxdsM UCF9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2026-07-10T18:48:23+00:00 2026-07-14T02:04:53+00:00 Targeting dysbiosis for therapy With Professor Robert Clancy, AM. DSc. PhD. FRACP. FRS(N). yt:video:FZ06PHBrgBw FZ06PHBrgBw UCF9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2026-07-06T19:48:17+00:00 2026-07-16T01:53:27+00:00 Subordinating information to political control Proposed UK rules could control your feed. Watch this Space https://www.gov.uk/government/consultations/watch-this-space-a-new-strategic-direction-for-uk-media-green-paper-and-public-consultation/watch-this-space-a-new-strategic-direction-for-uk-media-green-paper-and-public-consultation Keep YouTube Yours, Your Channel, Your Say YouTube is yours because you built it — view by view, subscriber by subscriber, on the merit of your ideas and your connection with your audience. However, proposed new rules could fundamentally change how your content is discovered, recommended, and viewed in the UK. The UK Government is running a public consultation called "Watch this space: a new strategic direction for UK media". The proposals include mandatory changes to how content is discovered on YouTube. This could direct audiences away from your channel. As a UK creator, this directly impacts your future. Digital content discovery works best when driven by user choice, not legal requirements. This is a vital window for you to share your perspective before the consultation closes on 31 August 2026. Impact of the Proposed Rules The proposed new rules include a mandatory "prominence regime". This could require digital platforms like YouTube to prioritise and give a "privileged position" to traditional broadcasters (like the BBC, ITV and Channel 4) in user interfaces and recommendation feeds, potentially pushing your content out of sight. Mandating prominence to traditional institutions will impact all other independent digital creators, production companies and media cos, including through: Your content downranked: Pushing this group forward means pushing everyone else downward. Mandatory prioritisation of broadcasters would affect how your content reaches your audience, regardless of what your audience actually wants to see. Reducing user exposure to diverse content & independent creators: Mandating prominence for established media networks would push the UK's diverse mix of independent journalists, educators, and digital-first businesses down the line. Threat to reach and channel growth: Your ability to organically grow your community, generate views and revenue, and build a sustainable business is compromised if your content is hard to be discovered. Undermining the creator-audience bond: The consultation repeatedly emphasises "trust" in the context of legacy broadcasters, implying that digital-first voices are less credible, damaging the foundational trust that sustains the creator economy. How to Get Involved The UK Government is seeking feedback from those affected by this upcoming legislation to help determine how online content should be regulated. Help protect the level playing field that you and all independent creators rely on by responding today. STEPS TO TAKE: Review the Proposals: Read the full breakdown of the UK Government's strategic framework for online media here: Read the Full Green Paper Access the Response Form: Submit feedback directly via the UK Government’s consultation website here: Official UK Gov Response Form. Click on section 4; news creator may also want to click on section 2. Useful information to share Give insights into how recommendations help you to find, connect with and build your audiences, and how being recommended less could disadvantage your channel. Share your thoughts on how such changes could disrupt the discovery of your work and your audience's experience. Tell your story. You work hard to build your channel in an ecosystem where success is determined by content quality and audience preferences, not regulatory mandates. Sections Relevant to You For all creators, please read: Chapter 4.1 (Prominence of PSM content in the platform age): Explores introducing state-mandated prominence for UK Public Service Broadcasting content above all other content and asking if this should also apply to general entertainment, comedy, drama, and sports. Question 24: Specifically asks you how proposed interventions might disrupt your business model. If you are a news creator, please read: • Chapter 2.2 (Prominence of news on social media): Proposals to mandate prioritisation of UK Public Service Broadcasting news content and government or regulator defined ‘trusted news’ providers. Deadline for responses: 31 August 2026 yt:video:VF3RHOFC354 VF3RHOFC354 UCF9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2026-07-05T13:24:39+00:00 2026-07-08T23:26:02+00:00 Ignored immune upgrade With Professor Robert Clancy, AM. DSc. PhD. FRACP. FRS(N). Full version of this video, https://www.youtube.com/watch?v=ZjjYaO1tIJM yt:video:wWQwhN5clOU wWQwhN5clOU UCF9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2026-07-04T14:13:30+00:00 2026-07-08T04:18:13+00:00 Medical detective Connective tissue disorder. With Dr. Michael Cohen. Check out Dr. Michael Cohen’s YouTube channel for more content, https://www.youtube.com/@UC01VYy_vGwx8QkmDgIw11oA yt:video:SjLKrnQn4MY SjLKrnQn4MY UCF9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2026-07-03T08:15:58+00:00 2026-07-08T23:28:07+00:00 New cancer prevention and treatment By Prof Angus Dalgleish MD FRCP FRACP FRCPath FMedSci My name is Professor Angus Dalgleish. I am an oncologist and immunologist with decades of experience in cancer immunotherapy and HIV research, including early clinical use of cancer immunotherapy in the United Kingdom long before checkpoint inhibitors were approved. I am Professor Emeritus and Foundation Chair of Oncology at the University of London, and Principal of the Institute of Cancer Vaccines and Immunotherapy. Beginning in late 2021, I observed a series of unexpected cancer relapses and unusually aggressive disease presentations among patients whose conditions had remained stable for years. A consistent pattern quickly became apparent: these relapses followed repeated COVID booster administration. These were patients in long-term remission who suddenly relapsed after being advised to receive additional doses of the vaccine. Despite the seriousness of these observations, there was little willingness to openly investigate these potential safety signals. From my background in HIV research and immunology, including early work involving the CD4 receptor, I was particularly sensitive to signals involving T-cell function and immune dysregulation. This led me to become concerned that repeated boosting strategies might contribute to impaired immune surveillance in vulnerable individuals, a concern later supported by evidence of exhausted T-cell responses following repeated vaccination. Over time, however, it became increasingly clear that the pattern extended far beyond relapse in vulnerable cancer patients alone. I began observing something far more alarming: unusually aggressive cancers, advanced-stage disease in younger individuals, and clinical presentations that differed sharply from what we would normally expect in routine oncology practice. Something broader — and far more concerning — appeared to be emerging. In my own clinical practice, I observed a marked increase in unexpected cancers among boosted patients, including breast, prostate, pancreatic, lymphoma, gall bladder, glioma, and bladder cancers. Some of the most striking observations came from colorectal cancer surgeons, who described a shift from earlier-stage, more routinely detected disease toward patients presenting with metastatic stage IV cancers and unusual thrombotic features. Increasingly, these patterns extended beyond clinical settings and into personal lives. I watched close friends develop aggressive late-stage cancers and rapidly deteriorate following repeated booster administration. At that point, the issue no longer felt purely academic or theoretical. It became deeply personal. I became increasingly concerned by unresolved questions surrounding the biologic behavior of mRNA-based platforms. Emerging literature proposed several biologically plausible mechanisms linking these vaccines to cancer progression, including immune dysregulation, vascular injury, and effects involving oncogenic and tumor-suppressor pathways. Additional issues involved residual DNA fragments and SV40 promoter/enhancer sequence elements identified in certain vaccine lots, findings which I believe warranted far greater regulatory scrutiny and independent investigation given their potential oncogenic implications. Through my previous work with mRNA experts and service on the Scientific Advisory Board of CureVac, I also became increasingly uneasy about questions involving biologic stability, genomic interaction, and the adequacy of long-term safety evaluation surrounding repeated mRNA exposure. For example, unresolved questions remain regarding potential interactions with cellular genetic processes, potentially activating cancer-promoting pathways while disrupting tumor suppression. The consistency of these clinical observations, combined with emerging mechanistic evidence, should have prompted far greater scientific scrutiny and open investigation than they received. Instead, many clinicians and researchers became increasingly hesitant to openly question or investigate these potential safety signals at all. As a UK citizen, I found it striking that several members of the Royal Family, who were vaccinated, publicly disclosed unexpected cancer diagnoses during the same period many clinicians were reporting unusually aggressive cancers more broadly. Given what we know already, I have no doubt in my mind that the mRNA vaccine likely played a significant role in the development of these unexpected cancers. I raise this not to imply certainty regarding any individual case, but to illustrate how difficult open scientific discussion surrounding these broader patterns has become, even when the observations are highly visible. yt:video:pUk_U2sS_zI pUk_U2sS_zI UCF9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2026-07-02T07:59:05+00:00 2026-07-07T06:36:39+00:00 Immunity from saliva With Professor Robert Clancy, AM. DSc. PhD. FRACP. FRS(N). yt:video:au7n8WUshyo au7n8WUshyo UCF9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2026-07-01T07:57:13+00:00 2026-07-01T07:58:00+00:00 Migraines, prevention and treatments Check out Dr. Michael Cohen’s YouTube channel for more content, https://www.youtube.com/@theaccidentaldr Scale of the problem — how big and disabling migraine really is • His 'upstream' idea — why he asks why it's happening, not just how to stop it 2. The investigation • What's usually missed in standard care • Key blood tests — omega-3, magnesium, iron, B12/folate/homocysteine, vitamin D, thyroid • Dosing — where the standard dose isint enough • A patient story or two 3. Sleep • Sleep as a medical issue, not just lifestyle advice • Sleep apnoea and migraine — the missed connection 4. Beyond the obvious • Blood pressure medications that also help migraine • The new CGRP drugs — what they do, what they don't address • Hormones and migraine in women • Riboflavin and CoQ10 — cheap, evidenced, rarely used 5. Devices • Cefaly and gammaCore — what they are, how they're used • Worth asking about any commercial ties 6. Closing • Pulling it all into one practical framework • Takeaway for GPs watching, and for migraine sufferers watching • Wrap and channel mention yt:video:Y1-L7weQNFk Y1-L7weQNFk UCF9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2026-06-30T17:54:21+00:00 2026-07-03T22:36:14+00:00 Project Africa Update Our foundation Go Fund Me link, https://www.gofundme.com/f/buwanga-way-to-health-foundation Our Buy Me a Coffee link, https://buymeacoffee.com/awmedicalvideos Link to campbellteaching donations for transfer to Africa https://www.paypal.com/donate/?hosted_button_id=XS59XPZ527YFL Direct bank transfers, for sterling and USD Direct Bank Transfer (Stanbic Bank Uganda - Mbale Branch) Account Holder: Wefwafwa Andrew Savings (USD): 9030027823571 Savings (GBP): 9030027823601 Branch Address: Republic Street (Plot 50/52), Mbale, Uganda SWIFT Code: SBICUGKX Link to Wefwafwa’s youtube channel, https://www.youtube.com/@WefwafwaAndrew Link to our organization's website: https://buwanga.org/ To contact Wefwafwa directly, wefandrew@gmail.com or WhatsApp+256756320736 yt:video:YVotKAXsLCE YVotKAXsLCE UCF9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2026-06-30T02:59:49+00:00 2026-07-05T06:27:13+00:00 They are contaminating our food Consider signing petition from Dr. Craig, https://petition.parliament.uk/petitions/769589 And this one https://petition.parliament.uk/petitions/751401 https://www.gov.uk/government/news/birth-defects-prevented-by-fortifying-flour-with-folic-acid https://www.food.gov.uk/safety-hygiene/folic-acid Detailed scientific paper from Dr. Clare Craig and Dr. Tim Kelly, https://www.researchgate.net/publication/396231370_Disruption_of_Cerebral_Folate_Metabolism_as_a_Unifying_Framework_for_Autism_Spectrum_Disorder_Risk_and_Causation_Running_title_Cerebral_folate_disruption_and_ASD Excellent books relating to covid by Dr. Craig, Spiked: UK: https://www.amazon.co.uk/Spiked-shot-dark-Covid-Autopsy/dp/1739344723 USA: https://www.amazon.com/Spiked-shot-dark-Covid-Autopsy/dp/1739344723 Canada: https://www.amazon.ca/Spiked-shot-dark-Covid-Autopsy/dp/1739344723 Australia: https://www.amazon.com.au/Spiked-shot-dark-Covid-Autopsy/dp/1739344723 Netherlands: https://www.amazon.com.be/Spiked-shot-dark-Covid-Autopsy/dp/1739344723 Expired: UK: https://www.amazon.co.uk/Expired-untold-Dr-Clare-Craig/dp/1739344707 USA: https://www.amazon.com/Expired-untold-Dr-Clare-Craig/dp/1739344707/ Canada: https://www.amazon.ca/Expired-untold-Dr-Clare-Craig/dp/1739344707/ Australia: https://www.amazon.com.au/Expired-untold-Dr-Clare-Craig/dp/1739344707/ Netherlands: https://www.amazon.com.be/Expired-untold-Dr-Clare-Craig/dp/1739344707 yt:video:S5Y_ShsPTpQ S5Y_ShsPTpQ UCF9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2026-06-27T22:19:19+00:00 2026-07-01T11:50:10+00:00 Low dose Naltrexone Important, ignored treatment in cancer. With Professor Angus Dalgleish MD FRCP FRACP FRCPath FMedSci yt:video:7snxImitBvk 7snxImitBvk UCF9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2026-06-26T21:33:41+00:00 2026-07-01T07:27:59+00:00 Myocarditis, vaccine evidence Detection of Vaccine-Derived Spike Protein Associated with Immune Cell Infiltration in the Heart and Liver: A Report of Two Cases (May 2026) https://www.mdpi.com/2073-4409/15/11/978 A landmark immunohistochemical study on COVID-19 mRNA vaccines (May 2026) https://substack.com/home/post/p-199670628 Rapid development of COVID-19 genetic vaccines Significant concerns Potential to trigger immune reactions against self-tissues. This mechanism was first proposed by Dr. Polykretis, who emphasised the necessity of bio-distribution studies to evaluate the risks associated with the spread of vaccine-derived genetic material beyond the injection site Histopathologically supported analysis How the synthesis of the vaccine-derived spike protein can trigger autoimmunity beyond the injection site. Characterised by robust immune cell recruitment. Delineates a pattern consistent with self-directed immune activity Including vaccine-associated myocarditis. Immune-cell infiltration, triggered by the synthesis of the vaccine-derived spike protein in the myocardium and liver We provide a detailed characterisation of the process and the immune cells involved, histopathological findings. Myocarditis case: A 72-year-old male who died from cryptogenic organizing pneumonia (COP), with histio-lymphocytic myocarditis identified as the main pathological condition. His vaccination history included two doses of AstraZeneca (April 2021, lot number: ABW2586; July 2021, lot number: 210094), one dose of Moderna (December 2021, lot number: 042G12A), and a booster dose of Pfizer/BioNTech (November 2022, 15 μg Original/Omicron BA.4-5). No known COVID-19 infection was recorded in the medical history. - Hepatitis case: An 86-year-old patient, with no known liver disease, who died from decompensated heart failure. The major concomitant condition was chronic obstructive pulmonary disease (COPD). The vaccination history included three doses of the Pfizer/BioNTech vaccine administered in March 2021 (lot number: ER2659 and EZT3674, for the first and second dose, respectively) and November 2021 (lot number: 1F1023A). No documented COVID-19 infection was reported in the medical history. Method Control samples Other literature consistent Differential diagnosis Understanding these mechanisms is essential for accurately assessing the potential implications of these vaccination technologies on human health. By emphasising the need for further research into the pharmacokinetics and off-target effects of COVID-19 genetic vaccines, this paper aims to deepen our understanding of their safety profiles and inform future vaccine development. yt:video:CTonBmfIzuA CTonBmfIzuA UCF9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2026-06-24T17:42:28+00:00 2026-06-24T18:01:50+00:00 Cancer and metabolism Check out Dr. Michael Cohen’s YouTube channel for more content, https://www.youtube.com/@theaccidentaldr yt:video:ZjjYaO1tIJM ZjjYaO1tIJM UCF9IOB2TExg3QIBupFtBDxg Dr. John Campbell https://www.youtube.com/channel/UCF9IOB2TExg3QIBupFtBDxg 2026-06-22T18:02:59+00:00 2026-06-23T08:15:27+00:00 Airway immunology With Professor Robert Clancy, AM. DSc. PhD. FRACP. FRS(N).